Pharmaceutics seminars are open to the public and offered weekly during the academic year.
Tuesdays 3:00 to 4:00 PM CT, Moos 5-125
Email [email protected] to request a Zoom link
January 21
Developing a Novel Peptide Targeting Tumor-Associated Macrophages via RXRB Recognition Through Molecular Docking
Nianwu Wang, PhD Candidate, Pang Lab
API Particle Engineering Through Microencapsulation for Successful Tableting
Tianyi Xiang, PhD Student, Sun Lab
January 28
Development of Tools for Sustainable Multicomponent Fluid Formulation
Lynn Walker, PhD, Professor, Department of Chemical Engineering and Materials Science, College of Science and Engineering, University of Minnesota-Twin Cities
February 4
Peptide Targeting to Improve the Delivery and Therapeutic Efficacy of Glucocorticoid Therapy
Mitch Kowalke, PhD Student, Pang Lab
Permeability Enhancement of Drugs by Cocrystallization - Issues and Future Directions
Pin-Syuan Huang, PhD Student, Sun Lab
February 11
Vulnerable Populations and Perinatal Cadmium Toxicity: The Placental Transporter BCRP/ABCG2 as a Protective Gatekeeper
Lauren Aleksunes, PhD, PharmD, DABT, Professor, Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University
February 18
Engineering Polymers to Improve the Delivery of "Difficult" Drugs
Chun Wang, PhD, Associate Professor, Department of Biomedical Engineering, College of Science and Engineering, University of Minnesota-Twin Cities
February 25
Scientific Foundations and Manufacturing Processes for Transdermal Patch Production
Marina Ruleva, PhD Student, Siegel & Kandimalla Labs
Critical Process Parameters for Fines Produced During Roller Compaction
Hae chan Kim, PhD Student, Sun Lab
March 4
Threading the Needle: Developing Potent Radiosensitizers While Limiting Normal Tissue Toxicities
Jann N. Sarkaria, MD, Professor, Department of Radiation Oncology, Mayo Clinic
March 11
No Seminar - Spring Break
March 18
Amyloid Beta Peptides Inhibit Insulin Trafficking at the Blood-Brain Barrier in Alzheimer's Disease Brain
Vaishnavi Veerareddy, PhD Student, Kandimalla Lab
Targeting Pan-FGFR Inhibitors to Solid Tumors
Ruisi Leng, PhD Student, Elmquist Lab
March 25
Integrating C.A.R.E.: Community, Advocacy, Resilience, and Empowerment in the Advancement of Pharmaceutics
L’Aurelle Johnson, PhD, MS, Associate Dean for Community, Advocacy, Resilience, and Empowerment, College of Pharmacy and Associate Professor, Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota-Twin Cities
April 1
Assessing Cells as Therapies for Brain Tumors
David Odde, PhD, Professor, Department of Biomedical Engineering, College of Science and Engineering, University of Minnesota-Twin Cities
April 8
Amyloid Beta Exposure Triggers Oxidative Stress in BBB Endothelial Cells and Impacts Extracellular Matrix Turnover
Vineetha Guttha, PhD Student, Kandimalla Lab
April 15
Modeling Feedback Loops Controlling Tumor Suppression
Prachi Shrivastav, PhD Student, Elmquist Lab
Disruption in Endothelial-Pericyte Interactions Leads to Pathological Angiogenesis in Alzheimer’s Disease
Muskan Badola, PhD Student, Kandimalla Lab
April 22
Using Digital Spatial Profiling to Elucidate Cellular Communications within the Neurovascular Unit
Lyle Nyberg, PhD Student, Kandimalla Lab
Tumor Evolution and PK/PD-Efficacy Modeling
Aran Kim, PhD Student, Elmquist Lab
April 29
Development of Agmatine Based Therapeutics for the Treatment of Chronic Pain and Opioid Addiction
Carolyn Fairbanks, PhD, Associate Dean for Research, College of Pharmacy and Professor, Department of Pharmaceutics, College of Pharmacy, University of Minnesota-Twin Cities
Strategically Substituted Agmatine Demonstrates High Maximum Tolerated Dose in Rats Following Intravenous Delivery
Riddhi Kini, PhD Student, Fairbanks Lab